prikaz prve stranice dokumenta Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
  Preuzmi
PDF 1.48 MB
Znanstveni rad - Izvorni znanstveni rad
Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
Diagnostics, 14 (2024), 13; 1383. https://doi.org/10.3390/diagnostics14131383
Radić, Josipa; Vučković, Marijana; Đogaš, Hana; Gelemanović, Andrea; Belančić, Andrej; Radić, Mislav

Citirajte ovaj rad

Radić, J., Vučković, M., Đogaš, H., Gelemanović, A., Belančić, A. i Radić, M. (2024). Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?. Diagnostics, 14. (13). doi: 10.3390/diagnostics14131383

Radić, Josipa, et al. "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?." Diagnostics, vol. 14, br. 13, 2024. https://doi.org/10.3390/diagnostics14131383

Radić, Josipa, Marijana Vučković, Hana Đogaš, Andrea Gelemanović, Andrej Belančić i Mislav Radić. "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?." Diagnostics 14, br. 13 (2024). https://doi.org/10.3390/diagnostics14131383

Radić, J., et al. (2024) 'Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?', Diagnostics, 14(13). doi: 10.3390/diagnostics14131383

Radić J, Vučković M, Đogaš H, Gelemanović A, Belančić A, Radić M. Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?. Diagnostics [Internet]. 28.06.2024. [pristupljeno 22.01.2025.];14(13). doi: 10.3390/diagnostics14131383

J. Radić, M. Vučković, H. Đogaš, A. Gelemanović, A. Belančić i M. Radić, "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?", Diagnostics, vol. 14, br. 13, Lipanj 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:575293. [Citirano: 22.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:575293
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
AutorJosipa Radić
AutorMarijana Vučković
AutorHana Đogaš
AutorAndrea Gelemanović
AutorAndrej Belančić
AutorMislav Radić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Klinička farmakologija s toksikologijom
Sažetak (engleski)
The aim of this cross-sectional study was to evaluate the differences in the levels of advanced glycation end products (AGE) between patients with chronic kidney disease (CKD) and kidney transplant recipients (KTRs) and to investigate the risk factors for the AGE levels in each group of these patients. There were 217 participants total, of which 99 (45.6%) were KTRs and 118 (54.4%) had CKD. Data on the levels of AGE, body mass composition, anthropometric parameters, central and peripheral blood pressure, and clinical and laboratory parameters were gathered for each study participant. The AGE values of the CKD and KTRs groups did not differ from one another. In both groups, a lower estimated glomerular filtration rate, male sex, and older age were positive predictors for increased AGE values. Furthermore, higher levels of AGE were linked to lower central systolic blood pressure (cSBP) in the CKD group, whilst, in the KTRs group, higher levels of AGE were linked to a shorter time since kidney transplantation (KTx), more years of dialysis prior to KTx, lower levels of trunk visceral fat, the presence of arterial hypertension, and the absence of prescriptions for the antihypertensive medications urapidil and angiotensin II receptor blockers. Further studies are needed to better understand the above associations. Consequently, a personalised multidisciplinary approach to assess the cardiovascular as well as dietary and lifestyle risk factors to reduce the AGE levels in both KTRs and CKD patients may be implemented.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaDiagnostics
Brojčani podacivol. 14, br. 13, 1383
e-ISSN2075-4418
DOIhttps://doi.org/10.3390/diagnostics14131383
URN:NBNurn:nbn:hr:184:575293
Datum objave publikacije2024-06-28
URL dokumentahttps://www.mdpi.com/2075-4418/14/13/1383
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-08-23 07:27:05